Topic: #avita-medical

Avita Medical Boosts 2026 Revenue Outlook on Q2 Sales Growth

Avita Medical, a regenerative medicine company, has raised its 2026 revenue outlook to $86 million–$89 million from $80 million–$85 million following a 18% year-over-year increase in Q2 sales to $21.7 million. The compan

2d agoavita-medicalrevenue-outlook

Avita Medical Aims for Q4 2025 Cash Flow Breakeven as Revenue Grows

Avita Medical Inc., a regenerative medicine company, has raised its 2025 revenue guidance to $86 million–$89 million. The company expects to reach cash flow breakeven in Q4 2025, supported by declining cash use, stable o

2d agoavita-medicalrevenue-growth